Phospholipase C gene expression, protein content, and activities in cardiac hypertrophy and heart failure due to volume overload

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 2 56-2, 2004, Pages

  Dent, Melissa R ^a   Dhalla, Naranjan S ^a   Tappia, Paramjit S ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

Cardiac sarcolemma; Signal transduction

Indexed keywords

INOSITOL 1,4,5 TRISPHOSPHATE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE; PHOSPHOLIPASE C; PHOSPHOLIPASE C DELTA1; PHOSPHOLIPASE C GAMMA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART MUSCLE FIBER MEMBRANE; HEART VENTRICLE HYPERTROPHY; HYPERVOLEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; SIGNAL TRANSDUCTION; VENTRICULOATRIAL SHUNT;

ANIMALS; CARDIAC OUTPUT, LOW; CARDIOMEGALY; CYTOSOL; DIGLYCERIDES; GENE EXPRESSION; HYPEREMIA; INOSITOL 1,4,5-TRISPHOSPHATE; ISOENZYMES; MALE; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PHOSPHOLIPASE C; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SARCOLEMMA; VENTRICULAR FUNCTION, LEFT;

EID: 3242658145     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01107.2003     Document Type: Article

References (51)

1. Akiyama Y, Ashizawa N, Seto S, Ohtsuru A, Kuroda H, Ito M, Yamashita S, and Yano K. Involvement of receptor-type tyrosine kinase gene families in cardiac hypertrophy. J Hypertens 17: 1329-1337, 1999.
2. Amin JK, Xiao L, Pimental DR, Pagano PJ, Singh K, Sawyer DB, and Colucci WS. Reactive oxygen species mediate α-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J Mol Cell Cardiol 33: 131-139, 2001.
3. Asemu G, Tappia PS, and Dhalla NS. Identification of the changes in phospholipase C isozymes in ischemic-reperfused rat heart. Biochim Biophys Acta 411: 174-182, 2003.
4. Braz JC, Bueno OF, De Windt LJ, and Molkentin JD. PKC α regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase 1/2 (ERK 1/2). J Cell Biol 156: 905-915, 2002.
5. Caroni P, Zurini M, and Clark A. The calcium-pumping ATPase of heart sarcolemma. Ann NY Acad Sci 402: 402-421, 1982.
6. D'Santos CS, Clarke JH, and Divecha N. Phospholipid signalling in the nucleus. Biochim Biophys Acta 1436: 201-232, 1998.
7. Detillieux KA, Sheikh F, Kardami E, and Cattini PA. Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res 57: 8-19, 2003.
8. Dhalla NS, Xu YJ, Sheu SS, Tappia PS, and Panagia V. Phosphatidic acid: a potential signal transducer for cardiac hypertrophy. J Mol Cell Cardiol 29: 2865-2871, 1997.
9. Dorn GW and Brown JH. Gq signaling in cardiac adaptation and maladaptation. Trends Cardiovasc Med 9: 26-34, 1999.
10. Dorn GW, Tepe NM, Wu G, Yatani A, and Liggett SB. Mechanisms of impaired β-adrenergic receptor signaling in Gαq-mediated cardiac hypertrophy and ventricular dysfunction. Mol Pharmacol 57: 278-287, 2000.
11. Duckworth BC and Cantley LC. PI 3-kinase and receptor-linked signal transduction. In: Handbook of Lipid Research. Lipid Second Messengers, edited by Bell RM, Exton JH, and Prescott SM. New York: Plenum, 1996, vol. 8, p. 125-175.
12. Eskildren-Helmond YEG, Bezstarosti K, Dekkers DHW, van Heugten HAA, and Lamers JMJ. Cross-talk between receptor-mediated phospholipase C β- and D via protein kinase C as intracellular signal possibly leading to hypertrophy in serum-free cultured cardiomyocytes. J Mol Cell Cardiol 29: 2545-2559, 1997.
13. Esler M, Kaye D, Lambert G, Esler D, and Jennings G. Adrenergic nervous system in heart failure. Am J Cardiol 80: 7L-14L, 1997.
14. Gilbert JC, Shirayama T, and Pappano AJ. Inositol triphosphate promotes Na-Ca exchange current by releasing calcium from sarcoplasmic reticulum in cardiac myocytes. Circ Res 69: 1632-1639, 1991.
15. Haendeler J and Berk BC. Angiotensin II mediated signal transduction. Important role of tyrosine kinases. Regul Pept 95: 1-7, 2000.
16. 2 in giant membrane patches. Science 273: 956-959, 1996.
17. 2 and its stabilization by Gβγ. Nature 391: 803-806, 1998.
18. 3 binding site in rat heart sarcoplasmic reticulum. J Mol Cell Cardiol 26: 341-349, 1994.
19. 1, and PKC. Cardiovasc Res 44: 5-9, 1999.
20. James SR and Downes CP. Structural and mechanistic features of phospholipases C: effectors of inositol phospholipid-mediated signal transduction. Cell Signal 9: 329-336, 1997.
21. Kacimi R and Gerdes AM. Alterations in G protein and MAP kinase signaling pathways during cardiac remodeling in hypertension and heart failure. Hypertension 41: 968-977, 2003.
22. Katan M. Families of phosphoinositide-specific phospholipase C: structure and function. Biochim Biophys Acta 1436: 5-17, 1998.
23. Kawaguchi H, Sano H, Iizuka K, Okada H, Kudo T, Kageyama K, Muramoto S, Murkami T, Okamoto H, and Mochizuki N. Phosphatidylinositol metabolism in hypertrophic rat heart. Circ Res 72: 966-972, 1993.
24. Kijima Y and Fleischer S. Two types of inositol triphosphate binding in cardiac microsomes. Biochem Biophys Res Commun 189: 728-735, 1992.
25. Kijima Y, Saito A, Jetton TL, Magnusson MA, and Fleischer S. Different intracellular localization of inositol 1,4,5-triphosphate and ryanodine receptors in cardiomyocytes. J Biol Chem 268: 3499-3506, 1993.
26. Lamers JM, Eskildsen-Helmond YE, Resink AM, DeJonge HW, Bezstarosti K, Sharma HS, and VanHeugten HA. Endothelin-1-induced phospholipase C β- and D and protein kinase C isoenzyme signaling leading to hypertrophy in rat cardiomyocytes. J Cardiovasc Pharmacol 26: S100-103, 1995.
27. Li YQ, Gao GD, Chu YL, and Gong XH. Dynamic changes of angiotensin II type-1 receptor mRNA expression in volume-overloaded ventricular hypertrophy [in Chinese]. Sheng Li Xue Bao 50: 303-308, 1998.
28. 2 isozymes in postinfarct congestive heart failure. Am J Physiol Cell Physiol 280: C573-C580, 2001.
29. Mende U, Kagan A, Cohen A, Aramburu J, Schoen FJ, and Neer EJ. Transient cardiac expression of constitutively active Gαq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc Natl Acad Sci USA 95: 13893-13898, 1998.
30. Minamino T, Yujiri T, Terada N, Taffet GE, Michael LH, Johnson GL, and Schneider MD. MEKK1 is essential for cardiac hypertrophy and dysfunction induced by Gq. Proc Natl Acad Sci USA 99: 3866-3871, 2002.
31. Opie LH. The neuroendocrinology of congestive heart failure. Cardiovasc J S Afr 13: 171-178, 2002.
32. Pettitt TR and Wakelam MJ. Diacylglycerol kinase ε, but not ζ, selectively removes polyunsaturated diacylglycerol, inducing altered protein kinase C distribution in vivo. J Biol Chem 274: 36181-36186, 1999.
33. Puceat M and Vassort G. Signalling by protein kinase C isoforms in the heart. Mol Cell Biochem 157: 65-72, 1996.
34. 2+ uptake mechanism in cardiac junctional sarcoplasmic reticulum. Biochem Biophys Res Commun 204: 69-75, 1994.
35. Rhee SG. Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem 70: 281-312, 2001.
36. Rhee SG and Bae YS. Regulation of phosphoinositide-specific phospholipase C isozymes. J Biol Chem 272: 15045-15048, 1997.
37. Sakata Y. Tissue factors contributing to cardiac hypertrophy in cardiomyopathic hamsters (BIO14.6): involvement of transforming growth factor-β1 and tissue renin-angiotensin system in the progression of cardiac hypertrophy [in Japanese]. Hokkaido Igaku Zasshi 68: 18-28, 1993.
38. Schafer M, Frischkopf K, Taimor G, Piper HM, and Schluter KD. Hypertrophic effect of selective β1-adrenoceptor stimulation on ventricular cardiomyocytes from adult rat. Am J Physiol Cell Physiol 279: C495-C503, 2000.
39. Schnabel P, Mies F, Nohr T, Geisler M, and Bohm M. Differential regulation of phospholipase C-β isozymes in cardiomyocyte hypertrophy. Biochem Biophys Res Commun 275: 1-6, 2000.
40. Shoki M, Kawaguchi H, Okamoto H, Sano H, Sawa H, Kudo T, Hirao T, Sakata Y, and Yasuda H. Phosphatidylinositol and inositolphosphatide metabolism in hypertrophied rat heart. Jpn Circ J 56: 142-147, 1992.
41. Takeda M, Kagaya Y, Takahashi J, Sugie T, Ohta J, Watanabe J, Shirato K, Kondo H, and Goto K. Gene expression and in situ localization of diacylglycerol kinase isozymes in normal and infracted rat hearts: effects of captopril treatment. Circ Res 89: 265-272.
42. Takeishi Y, Ping P, Bolli R, Kirkpatrick DL, Hoir BD, and Walsh RA. Transgenic overexpression of constitutively active protein kinase C ε causes concentric cardiac hypertrophy. Circ Res 86: 1218-1223, 2000.
43. Tappia PS, Liu SY, Shatadal S, Takeda N, Dhalla NS, and Panagia V. Changes in sarcolemmal PLC isoenzymes in postinfarct congestive heart failure: partial correction by imidapril. Am J Physiol Heart Circ Physiol 277: H40-H49, 1999.
44. Tappia PS, Maddaford TG, Hurtado C, Panagia V, and Pierce GN. Depressed phosphatidic acid-induced contractile activity of failing cardiomyocytes. Biochem Biophys Res Commun 300: 457-463, 2003.
45. Van Bilsen M. Signal transduction revisited: recent developments in angiotensin II signaling in the cardiovascular system. Cardiovasc Res 36: 310-322, 1997.
46. Varma DR and Deng XF. Cardiovascular α1-adrenoceptor subtypes: functions and signaling. Can J Physiol Pharmacol 78: 267-292, 2000.
47. Wang X, Ren B, Liu SY, Sentex E, Tappia PS, and Dhalla NS. Characterization of cardiac hypertrophy and heart failure due to volume overload in the rat. J Appl Physiol 94: 752-763, 2003.
48. Willenbrock R, Stauss H, Scheuermann M, Osterziel KJ, Unger T, and Dietz R. Effect of chronic volume overload on baroreflex control of heart rate and sympathetic nerve activity. Am J Physiol Heart Circ Physiol 273: H2580-H2585, 1997.
49. 1 alter the ligand binding, phospholipase activity, and interaction with the plasma membrane. J Biol Chem 273: 417-424, 1998.
50. Yu CH, Panagia V, Tappia PS, Liu SY, Takeda N, and Dhalla NS. Alterations of sarcolemmal phospholipase D and phosphatidate phosphohydrolase in congestive heart failure. Biochim Biophys Acta 1584: 65-72, 2002.
51. Ziegelhoffer A, Tappia PS, Mesaeli N, Sahi N, and Dhalla NS. Low level of sarcolemmal phosphatidylinositol 4,5-bisphosphate in cardiomyopathic hamster (UM-X7.1) heart. Cardiovasc Res 49: 118-126, 2001.